Tumor Marker Blood Test Doctors Abroad — Page 12

Dr. Kadri Yamac is an internist and hematologist. He earned his medical degree from Ankara University Faculty of Medicine (1976–1982). He completed Internal Medicine training at Gazi University Faculty of Medicine (1984–1989). He then completed a Hematology subspecialty at Gazi University Faculty of Medicine (1990–1993). He became an Associate Professor at Gazi University Faculty of Medicine in 1995. He was promoted to Professor in 2002.

Medical interests: anemias, coagulation disorders, hemochromatosis, chronic lymphocytic leukemia, lymph node diseases, non-Hodgkin lymphoma, Hodgkin lymphoma.

Prof. Dr. İbrahim Doğan is a gastroenterologist. He earned his MD from Ankara University Faculty of Medicine in 1991. He became an Internal Medicine specialist at Gazi University in 1996. He completed gastroenterology subspecialty training at İnönü University in 2001.

His academic career was at Gazi University. He served as Lecturer (2002), Assistant Professor (2003), Associate Professor (2007), and Professor (2012). He worked as a researcher at the University of California San Diego from 2004 to 2006. He has practiced at Koru Hospital since January 2023.

Clinical focus includes gastroesophageal reflux, irritable bowel syndrome, constipation, gastroparesis, achalasia, bloating, gas and belching, fecal incontinence, ulcerative colitis, and Crohn’s disease. He performs ERCP, stent placement, balloon and bougie dilation, polypectomy, argon plasma coagulation, double-balloon enteroscopy, and bleeding control.

Dr. Blanca Lopez Ibor leads the Hematology and Oncology Unit at HM Hospitales. She uses tumor marker blood tests to track pediatric cancers like leukemia and lymphomas.

• Trained in pediatric oncology and hematology at the University of Maryland in the USA
• Serves as an expert consultant for the WHO and UNESCO
• Expert for the Spanish Ministry of Health in pediatric oncology
• Member of the American Society of Hematology and the International Society of Pediatric Oncology
• Fellowship trained specialist in treating aggressive blood disorders and solid tumors

The doctor has conducted significant research on the cumulative effective dose of radiation from chest CT scans in COVID-19 patients. This work highlights the importance of adhering to guidelines to minimize unnecessary exposure, reflecting a commitment to patient safety and evidence-based practice.

Prof. Michael Truss is a FOCUS-recognized urologist who leads the German Cancer Society-accredited department at Dortmund Clinic.

• Directs the urology department and serves as an expert in oncourology – the study of urinary cancers
• Performs tumor marker blood tests to screen for and monitor prostate cancer
• Received clinical training at Johns Hopkins Hospital and an internship at Harvard University
• Published research in major journals like Andrology and the International British Journal of Urology
• Winner of the Jack Lapides Prize for his contributions to urodynamic research

Professor Bernd Hertenstein heads the Cancer Center and oncology department at Bremen-Mitte Clinic. This facility is recognized for high standards in tumor marker blood test screening and cancer care.

• Chief Physician at a hospital featured by the prestigious Focus magazine
• Specializes in cytogenetic studies to identify genetic mutations in cancer cells
• Directs treatment for leukemia, lymphoma, and various solid organ tumors
• Published researcher contributing to global advances in oncological care and radiotherapy
• Member of the medical faculty leading complex bone marrow transplantation programs